Mycophenolate in non-transplant disorders
نویسندگان
چکیده
NSW TAG wishes to thank the following persons who assisted in reviewing this document: Professor Jeremy Chapman (Westmead Hospital), Associate Professor Connie Katelaris (Westmead Hospital), Associate Professor Les Schrieber (Royal North Shore Hospital), Dr Michael Lee (Royal North Shore Hospital), Ms Ceridwen Jones (Royal Prince Alfred Hospital) and Mr Peter Barclay (Westmead Hospital). NSW TAG also acknowledges the assistance of Ms Rosalind Tindale who made a substantial contribution to an early draft of this paper.
منابع مشابه
Neoplastic Skin Complications in Transplant Patients: Experience of an Italian Multidisciplinary Transplant Unit
Transplant patients need to be strictly followed, since the immunosuppressive therapies they usually receive can increase the risk of skin complications. This study aims to evaluate the prevalence of neoplastic skin complications in transplant patients. We analyzed 256 liver or kidney transplant patients. The follow-up mean period was 7 ± 3.5 years. The 18.36% of patients developed neoplastic c...
متن کاملRelationship between post-transplant lymphoproliferative disorder and Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin
Abstract Background: Lymphoproliferative disorders are among the most serious and potentially fatal complications of chronic immunosuppression in kidney transplant recipients. The principle risk factors for development of PTLD are the degree of overall immunosuppression and the EBV serostatus of the recipient. In this study, the risk of PTLD in kidney transplant recipients who received Anti- L...
متن کاملInfectious complications after allogeneic bone marrow transplantation: Sheikha Badryia Center, Kuwait.
OBJECTIVE To present our experience of post-transplant infections in allogeneic stem cell transplants at Sheikha Badryia Stem Cell Transplant Centre, Kuwait. METHODS Retrospective analysis of 21 consecutive patients with malignant and non-malignant hematological disorders who received a transplant of an unmanipulated bone marrow graft from an HLAidentical sibling donor from November 2011 to D...
متن کاملQuestionnaire-based evaluation of gastrointestinal disorders in de novo renal-transplant patients receiving either mycophenolate mofetil or enteric-coated mycophenolate sodium.
BACKGROUND Gastrointestinal (GI) disorders are one of the main adverse events in patients treated by mycophenolic acid (MPA). The aim of our prospective questionnaire-based study was to assess GI side-effects in de novo renal-transplant patients receiving either mycophenolate mofetil (MMF) or enteric-coated mycophenolate sodium (EC-MPS). METHODS Between January 2002 and April 2003, all patien...
متن کاملEpstein-Barr virus infection in adult renal transplant recipients.
Epstein-Barr virus (EBV) DNAemia in the first year posttransplantation has been studied extensively. There is a paucity of information on prevalence and sequelae of EBV infection in adult renal transplantation beyond the first year. This single-center study examines the relationship between EBV DNAemia and demographic, immunosuppressive, hematologic and infection-related parameters in 499 renal...
متن کاملMycophenolate mofetil alters the antioxidant status in duodenum of rats: Implication for silymarin usage in mycophenolate mofetil-induced gastrointestinal disorders
Mycophenolate mofetil (MMF) as an immunosuppressive agent is used to prevent graft rejection. One of the adverse effects of long time administration of MMF is the gastrointestinal disorder. This study aimed to investigate the gastroprotective effect of silymarin (SMN) on MMF-induced gastrointestinal (GI) disorders. Twenty-four adult female Wistar rats were assigned into three groups including t...
متن کامل